论文部分内容阅读
目的探讨胃肠功能障碍(AGD)患儿给予肠内早期营养支持(EEN)时机选择的临床价值研究。方法选取本院儿童重症监护病房(PICU)2014年3月-2015年10月小儿危重病例评分(PCIS)78分~90分同时发生AGD的患儿101例,随机分为治疗组(51例)和对照组(50例)。观察2组患儿的AGD症状消失时间、治疗优良率、胃肠不良反应发生率、入住PICU时间、总住院时间、住PICU期间感染率、住PICU营养不良发生率、是否增加肠外营养治疗费用等的差异性。结果治疗组的治疗优良率高于对照组;治疗组胃肠道不良反应发生率、AGD症状消失时间、入住PICU时间、住PICU期间感染率、肠外营养治疗费用等低于对照组,差异均有统计学意义(P<0.05)。治疗组总住院时间、住PICU营养不良发生率等比较对照组差异无统计学意义(P>0.05)。结论胃肠功能障碍患儿于24 h或48 h内给予早期肠内营养,可以显著提高治疗有效率,减少胃肠道不良反应发生,缩短入住PICU时间,减少住PICU期间感染率,降低肠外营养治疗费用等,值得临床推广应用。
Objective To investigate the clinical value of timing of enteral early nutritional support (EEN) in children with gastrointestinal dysfunction (AGD). Methods A total of 101 children with AGD who underwent PICS between March 2014 and October 2015 in our pediatric critical care unit (PICU) from March 2014 to October 2015 were randomly divided into treatment group (51 cases) And control group (50 cases). To observe the disappearance of AGD symptoms, the excellent rate of treatment, the incidence of gastrointestinal adverse reactions, the time of PICU stay, the length of stay in hospital, the infection rate during PICU, the incidence of PICU malnutrition, whether to increase the cost of parenteral nutrition treatment And so the difference. Results The excellent and good rate of treatment in the treatment group was higher than that of the control group. The incidence of gastrointestinal adverse reactions, the disappearance of AGD symptoms, the time of PICU stay, the infection rate of PICU, the cost of parenteral nutrition treatment in the treatment group were lower than those in the control group. There was statistical significance (P <0.05). There were no significant differences in the total length of hospital stay and the incidence of PICU malnutrition in the control group (P> 0.05). Conclusion Children with gastrointestinal dysfunction give early enteral nutrition within 24 h or 48 h, which can significantly improve the treatment efficiency, reduce the incidence of gastrointestinal adverse reactions, shorten the time of PICU stay, reduce the infection rate during PICU, and reduce the parenteral Nutrition treatment costs, it is worth to promote clinical application.